Comex 信息 韩国 30 - pharmaceutical products 3002 - 人体或动物制品
圖形 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/WD-KR/1064/1/1/Fob/DepartureCountry-Date/All-South-Korea-Imports-1064-Year.png)
圖形 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/WD-KR/1064/1/1/Fob/DepartureCountry-Date/All-South-Korea-Imports-1064-Year.png)
表 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Export Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 美國 | 739.111.000 | 1.256.754.000 | 947.967.000 | 834.158.000 | 887.881.000 | 350.868.000 |
| 比利時 | 99.460.000 | 1.405.992.000 | 1.158.228.000 | 412.797.000 | 264.706.000 | 28.363.000 |
| 德國 | 327.312.000 | 718.709.000 | 511.181.000 | 439.970.000 | 457.604.000 | 192.324.000 |
| 土耳其 | 617.189.000 | 350.886.000 | 434.884.000 | 484.953.000 | 322.640.000 | 167.741.000 |
| 愛爾蘭 | 215.714.000 | 200.930.000 | 292.339.000 | 434.383.000 | 371.703.000 | 180.851.000 |
| 瑞士 | 283.552.000 | 381.159.000 | 259.986.000 | 257.229.000 | 255.032.000 | 124.544.000 |
| 新加坡 | 208.413.000 | 122.238.000 | 238.059.000 | 175.975.000 | 217.085.000 | 77.925.000 |
| 日本 | 110.970.000 | 150.354.000 | 163.490.000 | 217.506.000 | 150.080.000 | 58.239.000 |
| 丹麥 | 69.463.000 | 28.056.000 | 52.593.000 | 81.947.000 | 169.799.000 | 72.957.000 |
| 法國 | 53.382.000 | 65.747.000 | 57.141.000 | 83.071.000 | 160.978.000 | 30.635.000 |
| Others | 304.190.000 | 369.408.000 | 474.725.000 | 563.626.000 | 588.997.000 | 187.071.000 |
| Total | 3,028,756,000 | 5,050,233,000 | 4,590,593,000 | 3,985,615,000 | 3,846,505,000 | 1,471,518,000 |
圖形 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/WD-KR/1064/1/4/Fob/DepartureCountry-Date/All-South-Korea-Imports-1064-Month.png)
圖形 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/WD-KR/1064/1/4/Fob/DepartureCountry-Date/All-South-Korea-Imports-1064-Month.png)
表 - 韩国 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Export Countries
|
12 - 2024 | 01 - 2025 | 02 - 2025 | 03 - 2025 | 04 - 2025 | 05 - 2025 |
|---|---|---|---|---|---|---|
| 美國 | 78.813.000 | 62.080.000 | 81.804.000 | 93.660.000 | 53.699.000 | 59.625.000 |
| 德國 | 39.877.000 | 38.862.000 | 36.884.000 | 44.171.000 | 26.914.000 | 45.493.000 |
| 愛爾蘭 | 12.850.000 | 35.649.000 | 39.900.000 | 19.223.000 | 42.709.000 | 43.370.000 |
| 土耳其 | 13.901.000 | 28.630.000 | 12.866.000 | 50.573.000 | 24.560.000 | 51.112.000 |
| 瑞士 | 19.670.000 | 16.976.000 | 26.239.000 | 30.707.000 | 14.018.000 | 36.604.000 |
| 丹麥 | 23.465.000 | 29.950.000 | 3.669.000 | 12.908.000 | 21.637.000 | 4.793.000 |
| 日本 | 20.531.000 | 4.611.000 | 21.862.000 | 6.660.000 | 20.928.000 | 4.178.000 |
| 新加坡 | 668.000 | 6.710.000 | 658.000 | 37.690.000 | 18.639.000 | 14.228.000 |
| 比利時 | 27.715.000 | 16.248.000 | 3.626.000 | 2.612.000 | 3.026.000 | 2.851.000 |
| 法國 | 5.168.000 | 3.890.000 | 10.339.000 | 4.167.000 | 7.877.000 | 4.362.000 |
| Others | 45.114.000 | 33.904.000 | 36.226.000 | 39.274.000 | 47.330.000 | 30.337.000 |
| Total | 287,772,000 | 277,510,000 | 274,073,000 | 341,645,000 | 281,337,000 | 296,953,000 |
圖形 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/KR-WD/1064/2/1/Fob/DestinationCountry-Date/South-Korea-All-Exports-1064-Year.png)
圖形 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/KR-WD/1064/2/1/Fob/DestinationCountry-Date/South-Korea-All-Exports-1064-Year.png)
表 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Import Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 德國 | 1.840.096.000 | 1.745.830.000 | 621.836.000 | 480.282.000 | 527.806.000 | 611.626.000 |
| 美國 | 554.699.000 | 1.063.757.000 | 802.525.000 | 844.958.000 | 1.303.500.000 | 632.939.000 |
| 匈牙利 | 213.567.000 | 232.300.000 | 174.924.000 | 313.707.000 | 1.268.320.000 | 428.213.000 |
| 土耳其 | 583.676.000 | 353.043.000 | 516.054.000 | 363.155.000 | 415.703.000 | 183.149.000 |
| 瑞士 | 188.633.000 | 161.152.000 | 220.660.000 | 272.725.000 | 438.402.000 | 379.226.000 |
| 比利時 | 277.120.000 | 227.175.000 | 167.052.000 | 312.386.000 | 397.268.000 | 57.160.000 |
| 日本 | 149.670.000 | 312.693.000 | 271.933.000 | 375.166.000 | 204.329.000 | 40.718.000 |
| 荷蘭 | 330.107.000 | 257.712.000 | 92.739.000 | 207.195.000 | 202.521.000 | 211.345.000 |
| 義大利 | 60.348.000 | 186.857.000 | 325.408.000 | 268.636.000 | 324.491.000 | 98.223.000 |
| 巴西 | 165.090.000 | 146.044.000 | 186.127.000 | 156.277.000 | 197.254.000 | 66.196.000 |
| Others | 1.423.140.000 | 2.478.465.000 | 1.861.360.000 | 1.308.537.000 | 1.263.145.000 | 556.308.000 |
| Total | 5,786,146,000 | 7,165,028,000 | 5,240,618,000 | 4,903,024,000 | 6,542,739,000 | 3,265,103,000 |
圖形 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/KR-WD/1064/2/4/Fob/DestinationCountry-Date/South-Korea-All-Exports-1064-Month.png)
圖形 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/KR-WD/1064/2/4/Fob/DestinationCountry-Date/South-Korea-All-Exports-1064-Month.png)
表 - 韩国 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Import Countries
|
12 - 2024 | 01 - 2025 | 02 - 2025 | 03 - 2025 | 04 - 2025 | 05 - 2025 |
|---|---|---|---|---|---|---|
| 美國 | 86.190.000 | 174.338.000 | 73.698.000 | 123.424.000 | 80.473.000 | 181.006.000 |
| 德國 | 3.350.000 | 78.073.000 | 213.027.000 | 99.696.000 | 175.959.000 | 44.871.000 |
| 匈牙利 | 68.578.000 | 79.123.000 | 63.810.000 | 105.360.000 | 84.196.000 | 95.724.000 |
| 瑞士 | 61.851.000 | 62.206.000 | 72.305.000 | 66.069.000 | 59.153.000 | 119.493.000 |
| 荷蘭 | 42.305.000 | 37.392.000 | 59.800.000 | 35.055.000 | 50.992.000 | 28.106.000 |
| 土耳其 | 26.717.000 | 25.681.000 | 36.271.000 | 36.940.000 | 53.424.000 | 30.833.000 |
| 義大利 | 22.619.000 | 24.453.000 | 9.213.000 | 26.569.000 | 29.185.000 | 8.803.000 |
| 巴西 | 39.815.000 | 13.976.000 | 13.415.000 | 16.030.000 | 12.500.000 | 10.275.000 |
| 日本 | 29.350.000 | 3.817.000 | 3.439.000 | 10.940.000 | 12.839.000 | 9.683.000 |
| 中國大陸 | 7.986.000 | 5.147.000 | 12.083.000 | 5.837.000 | 13.394.000 | 15.216.000 |
| Others | 70.787.000 | 92.084.000 | 123.203.000 | 114.678.000 | 134.384.000 | 97.442.000 |
| Total | 459,548,000 | 596,290,000 | 680,264,000 | 640,598,000 | 706,499,000 | 641,452,000 |
圖形 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/KR-KR/1064/3/1/Fob/-/South-Korea-Import-Export-1064-Year.png)
圖形 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/KR-KR/1064/3/1/Fob/-/South-Korea-Import-Export-1064-Year.png)
表 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Export Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Importaciones | ||||||
| 美國 | 739.111.000 | 1.256.754.000 | 947.967.000 | 834.158.000 | 887.881.000 | 350.868.000 |
| 比利時 | 99.460.000 | 1.405.992.000 | 1.158.228.000 | 412.797.000 | 264.706.000 | 28.363.000 |
| 德國 | 327.312.000 | 718.709.000 | 511.181.000 | 439.970.000 | 457.604.000 | 192.324.000 |
| 土耳其 | 617.189.000 | 350.886.000 | 434.884.000 | 484.953.000 | 322.640.000 | 167.741.000 |
| 愛爾蘭 | 215.714.000 | 200.930.000 | 292.339.000 | 434.383.000 | 371.703.000 | 180.851.000 |
| 瑞士 | 283.552.000 | 381.159.000 | 259.986.000 | 257.229.000 | 255.032.000 | 124.544.000 |
| 新加坡 | 208.413.000 | 122.238.000 | 238.059.000 | 175.975.000 | 217.085.000 | 77.925.000 |
| 日本 | 110.970.000 | 150.354.000 | 163.490.000 | 217.506.000 | 150.080.000 | 58.239.000 |
| 丹麥 | 69.463.000 | 28.056.000 | 52.593.000 | 81.947.000 | 169.799.000 | 72.957.000 |
| 法國 | 53.382.000 | 65.747.000 | 57.141.000 | 83.071.000 | 160.978.000 | 30.635.000 |
| Others | 304.190.000 | 369.408.000 | 474.725.000 | 563.626.000 | 588.997.000 | 187.071.000 |
| Total | 3,028,756,000 | 5,050,233,000 | 4,590,593,000 | 3,985,615,000 | 3,846,505,000 | 1,471,518,000 |
|
Date
Import Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Exportaciones | ||||||
| 德國 | 1.840.096.000 | 1.745.830.000 | 621.836.000 | 480.282.000 | 527.806.000 | 611.626.000 |
| 美國 | 554.699.000 | 1.063.757.000 | 802.525.000 | 844.958.000 | 1.303.500.000 | 632.939.000 |
| 匈牙利 | 213.567.000 | 232.300.000 | 174.924.000 | 313.707.000 | 1.268.320.000 | 428.213.000 |
| 土耳其 | 583.676.000 | 353.043.000 | 516.054.000 | 363.155.000 | 415.703.000 | 183.149.000 |
| 瑞士 | 188.633.000 | 161.152.000 | 220.660.000 | 272.725.000 | 438.402.000 | 379.226.000 |
| 比利時 | 277.120.000 | 227.175.000 | 167.052.000 | 312.386.000 | 397.268.000 | 57.160.000 |
| 日本 | 149.670.000 | 312.693.000 | 271.933.000 | 375.166.000 | 204.329.000 | 40.718.000 |
| 荷蘭 | 330.107.000 | 257.712.000 | 92.739.000 | 207.195.000 | 202.521.000 | 211.345.000 |
| 義大利 | 60.348.000 | 186.857.000 | 325.408.000 | 268.636.000 | 324.491.000 | 98.223.000 |
| 巴西 | 165.090.000 | 146.044.000 | 186.127.000 | 156.277.000 | 197.254.000 | 66.196.000 |
| Others | 1.423.140.000 | 2.478.465.000 | 1.861.360.000 | 1.308.537.000 | 1.263.145.000 | 556.308.000 |
| Total | 5,786,146,000 | 7,165,028,000 | 5,240,618,000 | 4,903,024,000 | 6,542,739,000 | 3,265,103,000 |
圖形 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/KR-KR/1064/3/4/Fob/-/South-Korea-Import-Export-1064-Month.png)
圖形 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/KR-KR/1064/3/4/Fob/-/South-Korea-Import-Export-1064-Month.png)
表 - 韩国 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Export Countries
|
12 - 2024 | 01 - 2025 | 02 - 2025 | 03 - 2025 | 04 - 2025 | 05 - 2025 |
|---|---|---|---|---|---|---|
| Importaciones | ||||||
| 美國 | 78.813.000 | 62.080.000 | 81.804.000 | 93.660.000 | 53.699.000 | 59.625.000 |
| 德國 | 39.877.000 | 38.862.000 | 36.884.000 | 44.171.000 | 26.914.000 | 45.493.000 |
| 愛爾蘭 | 12.850.000 | 35.649.000 | 39.900.000 | 19.223.000 | 42.709.000 | 43.370.000 |
| 土耳其 | 13.901.000 | 28.630.000 | 12.866.000 | 50.573.000 | 24.560.000 | 51.112.000 |
| 瑞士 | 19.670.000 | 16.976.000 | 26.239.000 | 30.707.000 | 14.018.000 | 36.604.000 |
| 丹麥 | 23.465.000 | 29.950.000 | 3.669.000 | 12.908.000 | 21.637.000 | 4.793.000 |
| 日本 | 20.531.000 | 4.611.000 | 21.862.000 | 6.660.000 | 20.928.000 | 4.178.000 |
| 新加坡 | 668.000 | 6.710.000 | 658.000 | 37.690.000 | 18.639.000 | 14.228.000 |
| 比利時 | 27.715.000 | 16.248.000 | 3.626.000 | 2.612.000 | 3.026.000 | 2.851.000 |
| 法國 | 5.168.000 | 3.890.000 | 10.339.000 | 4.167.000 | 7.877.000 | 4.362.000 |
| Others | 45.114.000 | 33.904.000 | 36.226.000 | 39.274.000 | 47.330.000 | 30.337.000 |
| Total | 287,772,000 | 277,510,000 | 274,073,000 | 341,645,000 | 281,337,000 | 296,953,000 |
|
Date
Import Countries
|
12 - 2024 | 01 - 2025 | 02 - 2025 | 03 - 2025 | 04 - 2025 | 05 - 2025 |
|---|---|---|---|---|---|---|
| Exportaciones | ||||||
| 美國 | 86.190.000 | 174.338.000 | 73.698.000 | 123.424.000 | 80.473.000 | 181.006.000 |
| 德國 | 3.350.000 | 78.073.000 | 213.027.000 | 99.696.000 | 175.959.000 | 44.871.000 |
| 匈牙利 | 68.578.000 | 79.123.000 | 63.810.000 | 105.360.000 | 84.196.000 | 95.724.000 |
| 瑞士 | 61.851.000 | 62.206.000 | 72.305.000 | 66.069.000 | 59.153.000 | 119.493.000 |
| 荷蘭 | 42.305.000 | 37.392.000 | 59.800.000 | 35.055.000 | 50.992.000 | 28.106.000 |
| 土耳其 | 26.717.000 | 25.681.000 | 36.271.000 | 36.940.000 | 53.424.000 | 30.833.000 |
| 義大利 | 22.619.000 | 24.453.000 | 9.213.000 | 26.569.000 | 29.185.000 | 8.803.000 |
| 巴西 | 39.815.000 | 13.976.000 | 13.415.000 | 16.030.000 | 12.500.000 | 10.275.000 |
| 日本 | 29.350.000 | 3.817.000 | 3.439.000 | 10.940.000 | 12.839.000 | 9.683.000 |
| 中國大陸 | 7.986.000 | 5.147.000 | 12.083.000 | 5.837.000 | 13.394.000 | 15.216.000 |
| Others | 70.787.000 | 92.084.000 | 123.203.000 | 114.678.000 | 134.384.000 | 97.442.000 |
| Total | 459,548,000 | 596,290,000 | 680,264,000 | 640,598,000 | 706,499,000 | 641,452,000 |
